Pradaxa Update Warning from Mike Lewis Attorneys

(LegalLaw247.com, December 05, 2012 ) WINSTON-SALEM, NC - A new announcement from the FDA indicates that following their evaluation, Pradaxa users did not find an increased risk of bleeding when compared with the use of a associated drug, warfarin. While this announcement was in fact truthful, the FDA failed to state that the drug warfarin includes a reversal agent which would be essential in the event where a bleeding emergency is arises. Pradaxa, on the contrary, does not include an antidote which would be imperative for anticlotting and the prevention of severe and possibly fatal bleeds. For more information, please visit: http://www.mikelewisattorneys.com/.

Agencies outside of the United States are also concerned with Pradaxa internal bleeding deaths. European regulators have recommended that patients who may begin a Pradaxa regimen should first have their kidneys checked by a physician. An elderly patient with weak kidneys runs a higher risk of suffering from internal bleeding.

Over 100 lawsuits have been filed in regard to the adverse effects after use of the drug Pradaxa to date. If you or someone you love has suffered from internal bleeding after taking Pradaxa, contact our dangerous drug attorneys as soon as possible. You may be eligible to receive compensation for medical bills, lost wages, pain and suffering.

About Mike Lewis Attorneys

A well-respected name in personal injury law, Mike Lewis Attorneys is committed to helping individuals who have been injured by the actions of another in the state of North Carolina. The personal injury lawyers at Mike Lewis Attorneys have a wealth of knowledge and experience in auto injury claims, premises liability, dangerous drug litigation, product liability claims and bankruptcy litigation. Visit Mike Lewis Attorneys online at http://www.mikelewisattorneys.com for a free case evaluation and more information about your legal rights.

Mike Lewis Attorneys
PMP Marketing Group
561-253-6712
pressrelease@pmpmg.com

Source: EmailWire.Com